9,994.35-67.2
Stock Analysis, IPO, Mutual Funds, Bonds & More

Coronavirus: Mankind Pharma pledges Rs 51 crore for CM relief funds

The funds would be utilised for procuring ventilators, personal protective equipment (PPE) and medicines for the states reporting maximum number of positive cases, it said. The company said it will be working closely with various state governments including Kerala, Maharashtra, Uttar Pradesh, Uttarakhand, Bihar, Tamil Nadu, and Karnataka, among others.

PTI|
Last Updated: Mar 30, 2020, 04.50 PM IST
0Comments
mankind
"Being the leading pharma company of India, we would like the fund to be utilised for providing protective equipment to medical front-line warriors and ventilators to those who have already caught the virus," Mankind Pharma Chairman R C Juneja said.
Coronavirus

COVID-19 CASES

Confirmed
216,919
Deaths
6,075
New Delhi: Mankind Pharma on Monday said it is donating Rs 51 crore to CM relief funds of various states in order to help them fight the coronavirus pandemic. With growing number of COVID-19 cases in India, the company joins the fight by donating Rs 51 crore to CM relief funds to manage this disaster, Mankind Pharma said in a statement.

The funds would be utilised for procuring ventilators, personal protective equipment (PPE) and medicines for the states reporting maximum number of positive cases, it added.

The company said it will be working closely with various state governments including Kerala, Maharashtra, Uttar Pradesh, Uttarakhand, Bihar, Tamil Nadu, and Karnataka, among others.

"Being the leading pharma company of India, we would like the fund to be utilised for providing protective equipment to medical front-line warriors and ventilators to those who have already caught the virus," Mankind Pharma Chairman R C Juneja said.

The number of coronavirus cases in India have already crossed the 1,000-mark.
(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Also Read

Mankind Pharma launches drug for treatment of infertility in India

Mankind Pharma eyes $1 billion topline by 2021

ChrysCapital set to acquire 10% in Mankind for $350 million

Sushma Swaraj says terrorism 'existentialist danger' to mankind

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service